Lacticaseibacillus rhamnosus/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Lacticaseibacillus rhamnosus — no detected effect on serum leptin
Evidence strength: moderate.FindingNull result“Leptin levels decreased after the 3-month study period (p = 0.045), with no differences with probiotic supplementation.”
Quoted verbatim from PROFAST: A Randomized Trial Assessing the Effects of Intermittent Fasting and Lacticaseibacillus rhamnosus Probiotic among People with Prediabetes.. - Study
- RCT
- Duration
- 3 months
- Dose
- one capsule daily, 6 x 10^9 CFU, for 12 weeks
- Population
- Adults aged 18 to 65 with prediabetes and obesity, all following a 5:2 intermittent fasting regimen in both arms; 26 completers (15 probiotic, 11 placebo)
PROFAST: A Randomized Trial Assessing the Effects of Intermittent Fasting and Lacticaseibacillus rhamnosus Probiotic among People with Prediabetes.2020PMID:3321290710.3390/nu12113530Industry fundedPermalink
To cite this finding: https://catalystproject.ai/e/01M5MGR85NHJG66YAC4VRMMZW6